Morphic Holding, Inc. (MORF)
NASDAQ: MORF · IEX Real-Time Price · USD
56.52
+0.20 (0.36%)
At close: Jul 19, 2024, 4:00 PM
56.45
-0.07 (-0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Morphic Holding Employees
Morphic Holding had 121 employees as of December 31, 2023. The number of employees increased by 19 or 18.63% compared to the previous year.
Employees
121
Change (1Y)
19
Growth (1Y)
18.63%
Revenue / Employee
n/a
Profits / Employee
-$1,332,678
Market Cap
2.83B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 121 | 19 | 18.63% |
Dec 31, 2022 | 102 | 1 | 0.99% |
Dec 31, 2021 | 101 | 12 | 13.48% |
Dec 31, 2020 | 89 | 13 | 17.11% |
Dec 31, 2019 | 76 | 17 | 28.81% |
Dec 31, 2018 | 59 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Envista Holdings | 12,800 |
Azenta | 3,500 |
LivaNova | 2,900 |
Tandem Diabetes Care | 2,400 |
agilon health | 1,117 |
ACADIA Pharmaceuticals | 598 |
MorphoSys AG | 524 |
MORF News
- 1 day ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders - GlobeNewsWire
- 2 days ago - MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF - Business Wire
- 2 days ago - SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Morphic Holding, Inc. – MORF - GlobeNewsWire
- 10 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders - GlobeNewsWire
- 12 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, DM on Behalf of Shareholders - PRNewsWire
- 13 days ago - Shareholder Alert: Ademi LLP investigates whether Morphic Holding, Inc. has obtained a Fair Price for its Public Shareholders - PRNewsWire
- 13 days ago - Eli Lilly Buys Morphic for $3.2B - Investopedia
- 13 days ago - Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal - Forbes